Cannabis News

maybe because cannabis ( actual green dried plant matter ) is being used as medical in so many places already then sched 2 could be different with this plant?? or they pull the wool over our eyes prescribing GW weed only as an oil or in patches and tell people it is medical weed... first huge problem- cost$, next supply... we will rely on one supplier for everybody???

Also, sched 2 does not recognize nor recommend plants as medicines just the actual " drugs" that are made from plants that they don't tell the people about. these " drugs" too are usually synthetic representatives of the real thing missing the "vital life principle " for health.

at the cost of health for people who could be storing their healthy medicine ( retaining active compounds) via life form plants ( buds/flowers) we will rely on them packaging ( retaining compounds synthetically) those compounds and distributing at a huge loss of " vital life ". the vital life compounds would have to be irradiated and god knows what else to keep the compounds from spoiling from their mass transport system etc....

all of a sudden medical cannabis will not be doing the things it was before re scheduling simply because the power of the plant was dowsed with pure robot logic of mass produce synthetically one compound only to distribute out to every freaking one

After having done some investigation into this article and the "newspaper" that broke it I would argue the story is likely a complete fabrication.

Hang in there MMJ patients!


.

Although I think the Dutch laws surrounding cannabis are far from ideal, everytime I read this thread (or any post of a fc member stating they don't have a reliable source) I realize how lucky I am.

Snopes: Schedule 2 move just speculation

[T]here is as yet no indication that the information published on the topic was accurate, and there has been no official confirmation the DEA would moving in that direction on 1 August 2016.

macbill said:

Snopes: Schedule 2 move just speculation

[T]here is as yet no indication that the information published on the topic was accurate, and there has been no official confirmation the DEA would moving in that direction on 1 August 2016.

Click to expand...

They should de-schedule it completely!

I wonder if this is a true story? Awesome if it is. I just found it and couldn't wait to post. It's a current article. Sorry I saw at the bottom after posting it, it said "satire". I should have known the dispensary tender was named Scooby. I deleted some of it. False alarm. I was going to delete the whole thing. Even though not true it's funny.
CK

MANHATTAN, NY - NOVEMBER 05, 2013: Former President Jimmy Carter seen leaving Good Morning America on NOVEMBER 05, 2013 in New York (Photo By Josiah KamauBuzzFoto.com) Buzz Foto LLC httpwww.buzzfoto.com 1112 Montana Ave suite 80 Santa Monica CA 90403 1 310 980 8822 1 310 691 3888 Local Caption *** Jimmy Carter
Jimmy Carter: “Medical Marijuana Cured My Cancer”
0
BY TNM NEWS ON JUNE 21, 2016FEATURED, LATEST HEADLINES, LIFESTYLE, NEWS FEED


Cannasos reports:

By Jacqueline Austin

The Nobel winner thanked his doctors and family for their support through his brain cancerordeal. He also thanked Terrance ‘Scooby’ Williams of Dr. Green’s Greenery, a pot dispensary in Oakland, CA, for helping him find the right strain of cannabis.

Carter told his medicinal regiment to Sawyer“I smoke two joints in the morning, I smoke two joints at night, I smoke two joint in the afternoon, and it makes me feel all right.

“Edibles are also good when traveling when smoking is not permitted.”

The future is bright for the 91-year-old humanitarian. Carter has resumed his house building for Habitat for Humanity and continues his weekly prayer service. “Marijuana is God’s medicine. I find indica is better than sativa, but there are plenty of good hybrids.“

Carter wasn’t endorsing pot smoking for everyone. “There is the right place and the right time to spark up a bowl. Don’t be a pothead but also be aware of the potential benefits of cannabis when used in moderation with the right music.

Good news in Jamaica, I'm curious about how their retail market develops

Never heard of it before but Freetown Christiana in Copenhagen.
The authorities have "Raided Pusher street again"!
Seems like a hippy outdoor weed market every Friday in a squatter type area and the fuzz really came down heavy on it.

"According to reports, cannabis sales resumed within minutes of police leaving Pusher Street, leading many to wonder what actual purpose the action served."

Yay for them! And at least now it has sparked a legalization debate.
Not sure if I'd like to be selling there next Friday though!

http://www.thelocal.dk/20160618/copenhagen-police-tear-down-christiania-cannabis-market

http://www.thelocal.dk/20160621/new-debate-on-cannabis-legalization-after-christiania-raid

That has been going on for years over there. When I was there the police came in wearing full riot gear. It was a surreal scene.

Not good news for Cannabusinesses wanting more traditional banking options.

You can read the article HERE.

Congressional sponsors of an amendment to give cannabis businesses easier access to banking services railed against the rejection of the proposal by a House committee earlier today.

Perlmutter and Heck both made reference to a recent incident in Aurora, Colo., where a security guard was shot and killed during an armed robbery of Green Heart Marijuana Dispensary. The shooting highlights the dangers that cannabis business operators face every day due to the nature of a cash industry.

“How many more armed robberies must we witness and security guards lives lost before we take action?” asked Perlmutter.

The amendment was blocked earlier today by the House Rules Committee.

This isn’t the first attempt at removing banking hurdles facing the legal marijuana industry. Sens. Jeff Merkley (D-Ore.) and Patty Murray (D-Wash.) introduced a similar amendment last year that passed through the Senate Appropriations committee with a 16–14 vote before being stripped from the final appropriations bill.

While this is a disappointing, albeit not entirely unexpected, turn of events, not all hope is lost. If the Senate passes its own appropriations bill with the cannabis banking rider, the House will have a chance to approve or reject the amendment.

Carol,

I hadn't seen this particular article, but I know people close to him and he did indeed benefit from medical cannabis as part of his treatment. He was also using some of the latest techniques to kill off the glioblastoma that grew after his diagnosis with metastatic melanoma. Immunotherapies. Good combo, I'd say! Knowing the parties involved, they likely bought him a vaporizer and made him hand-made edibles while he was being treated.

CarolKing said:

I wonder if this is a true story? Awesome if it is. I just found it and couldn't wait to post. It's a current article. Sorry I saw at the bottom after posting it, it said "satire". I should have known the dispensary tender was named Scooby. I deleted some of it. False alarm. I was going to delete the whole thing. Even though not true it's funny.
CK

MANHATTAN, NY - NOVEMBER 05, 2013: Former President Jimmy Carter seen leaving Good Morning America on NOVEMBER 05, 2013 in New York (Photo By Josiah KamauBuzzFoto.com) Buzz Foto LLC httpwww.buzzfoto.com 1112 Montana Ave suite 80 Santa Monica CA 90403 1 310 980 8822 1 310 691 3888 Local Caption *** Jimmy Carter
Jimmy Carter: “Medical Marijuana Cured My Cancer”
0
BY TNM NEWS ON JUNE 21, 2016FEATURED, LATEST HEADLINES, LIFESTYLE, NEWS FEED


Cannasos reports:

By Jacqueline Austin

The Nobel winner thanked his doctors and family for their support through his brain cancerordeal. He also thanked Terrance ‘Scooby’ Williams of Dr. Green’s Greenery, a pot dispensary in Oakland, CA, for helping him find the right strain of cannabis.

Carter told his medicinal regiment to Sawyer“I smoke two joints in the morning, I smoke two joints at night, I smoke two joint in the afternoon, and it makes me feel all right.

“Edibles are also good when traveling when smoking is not permitted.”

The future is bright for the 91-year-old humanitarian. Carter has resumed his house building for Habitat for Humanity and continues his weekly prayer service. “Marijuana is God’s medicine. I find indica is better than sativa, but there are plenty of good hybrids.“

Carter wasn’t endorsing pot smoking for everyone. “There is the right place and the right time to spark up a bowl. Don’t be a pothead but also be aware of the potential benefits of cannabis when used in moderation with the right music.

Click to expand...

Alaska Marijuana News
Why the next president could be a buzzkill for pot advocates
While Trump and his Democratic rival, former Secretary of State Hillary Clinton, both say they'd follow the lead of President Barack Obama in leaving legalization to states, many fear that the GOP presidential nominee could easily reverse course. They note Trump's ties to two of the country's most ardent opponents to legalization: New Jersey Republican Gov. Chris Christie and Sheldon Adelson, a multibillionaire casino magnate from Las Vegas.

"He could change his mind in five minutes," said Allen St. Pierre, executive director of the National Organization for the Reform of Marijuana Laws, a pro-legalization group. "It's almost impossible to know exactly what he actually believes because he has said so many different things and contradicted himself."

Of the two, St. Pierre said that Christie, a former federal prosecutor, poses the biggest threat.

Christie, regarded as one of Trump's top candidates for attorney general, is already making plans for the New York billionaire to take over as president, serving as the chairman of his transition team. He endorsed Trump after ending his own presidential bid, but not before riling pot backers by pledging to enforce all federal marijuana laws.

"He was the most virulently anti-marijuana candidate," St. Pierre said. "If you're in the marijuana business, you've got to be way, way, way more concerned about Chris Christie being attorney general."

Other legalization advocates are fretting over Adelson, who ranks as one of the nation's top Republican donors.

Adelson caused a stir in December when he bought the Las Vegas Review-Journal, Nevada's largest newspaper. Two weeks ago, the paper shocked marijuana backers by reversing its long history of support for legalization.

In an editorial, the newspaper urged voters to reject a measure to legalize marijuana in November, calling it "a bad bet for Nevada" that would jeopardize public health and lead to more drug abuse and addiction.

Legalization backers say it shows the influence of Adelson, who also used his money to help defeat Florida's medical marijuana ballot initiative in 2014.

"I can't help but see this as yet another attempt by a wealthy, sycophantic conservative to subvert the will of American voters," said Derek Peterson, chief executive officer of Terra Tech Corp., a publicly traded marijuana company. "It's a disgrace that Mr. Adelson would pressure the newsroom at the Las Vegas Review-Journal to do his bidding."

Craig Moon, the newspaper's publisher, took credit for assigning the editorial.

"I am aware of the (Adelson) family views of which I personally agree. The editorial page reports to me," Moon said in an email.

And J. Keith Moyer, former publisher of the Minneapolis Star Tribune and now the editor of the Las Vegas newspaper, said the newsroom has not cut back on its marijuana coverage, offering readers two stories on the issue in the last week alone.

"Trust me, we are all over the topic," Moyer said in an email.

The New York Times reported that Adelson met privately with Trump last month, promising to contribute more than $100 million to help elect Trump. The newspaper cited two anonymous Republicans with direct knowledge of Adelson's commitment.

Kleiman said legalization backers in Washington state and elsewhere will have plenty of reason to worry if Trump wins and starts taking advice from Adelson on marijuana issues.

oh lord, shoot me now

CarolKing said:

Alaska Marijuana News
Why the next president could be a buzzkill for pot advocates
While Trump and his Democratic rival, former Secretary of State Hillary Clinton, both say they'd follow the lead of President Barack Obama in leaving legalization to states, many fear that the GOP presidential nominee could easily reverse course. They note Trump's ties to two of the country's most ardent opponents to legalization: New Jersey Republican Gov. Chris Christie and Sheldon Adelson, a multibillionaire casino magnate from Las Vegas.

"He could change his mind in five minutes," said Allen St. Pierre, executive director of the National Organization for the Reform of Marijuana Laws, a pro-legalization group. "It's almost impossible to know exactly what he actually believes because he has said so many different things and contradicted himself."

Of the two, St. Pierre said that Christie, a former federal prosecutor, poses the biggest threat.

Christie, regarded as one of Trump's top candidates for attorney general, is already making plans for the New York billionaire to take over as president, serving as the chairman of his transition team. He endorsed Trump after ending his own presidential bid, but not before riling pot backers by pledging to enforce all federal marijuana laws.

"He was the most virulently anti-marijuana candidate," St. Pierre said. "If you're in the marijuana business, you've got to be way, way, way more concerned about Chris Christie being attorney general."

Other legalization advocates are fretting over Adelson, who ranks as one of the nation's top Republican donors.

Adelson caused a stir in December when he bought the Las Vegas Review-Journal, Nevada's largest newspaper. Two weeks ago, the paper shocked marijuana backers by reversing its long history of support for legalization.

In an editorial, the newspaper urged voters to reject a measure to legalize marijuana in November, calling it "a bad bet for Nevada" that would jeopardize public health and lead to more drug abuse and addiction.

Legalization backers say it shows the influence of Adelson, who also used his money to help defeat Florida's medical marijuana ballot initiative in 2014.

"I can't help but see this as yet another attempt by a wealthy, sycophantic conservative to subvert the will of American voters," said Derek Peterson, chief executive officer of Terra Tech Corp., a publicly traded marijuana company. "It's a disgrace that Mr. Adelson would pressure the newsroom at the Las Vegas Review-Journal to do his bidding."

Craig Moon, the newspaper's publisher, took credit for assigning the editorial.

"I am aware of the (Adelson) family views of which I personally agree. The editorial page reports to me," Moon said in an email.

And J. Keith Moyer, former publisher of the Minneapolis Star Tribune and now the editor of the Las Vegas newspaper, said the newsroom has not cut back on its marijuana coverage, offering readers two stories on the issue in the last week alone.

"Trust me, we are all over the topic," Moyer said in an email.

The New York Times reported that Adelson met privately with Trump last month, promising to contribute more than $100 million to help elect Trump. The newspaper cited two anonymous Republicans with direct knowledge of Adelson's commitment.

Kleiman said legalization backers in Washington state and elsewhere will have plenty of reason to worry if Trump wins and starts taking advice from Adelson on marijuana issues.

Click to expand...

I think the public would revolt if Christie opened up his doughnut hole and pushed to roll-back state efforts towards legalization.

The genie is out of the bottle, so to speak.

I've never been excited by them re-scheduling cannabis on the CSA, there is no reason for it to be on ANY schedule aside from MONEY. I mean good gawd, they already carved out protection for BigPharma and have licensed the U.S. Patent to 2 companies that I recall so far.

Schedule 2... so my oncologist can now actually write me a -prescription-, that mean insurance will now cover it? That patients are now provided employment protections? _RIGHT_ (Monty Python style, but in disbelief)

Sadly, I think only Bernie was looking at a wholesale shakeup of how we look at and deal with drugs.

Christie is a cromagnon idiot, and the fact that he attached himself to Trump is proof enough of what a sycophant he is to get closer to power. He and Trump will take us back to the 50's in a very bad way.

Earlier today this article (see link below) in the WSJ said that the FDA decision on rescheduling cannabis is binding for the DEA, and that as we already knew, the DEA has been in receipt of the FDA's decision since last September. Geez, you don't suppose the DEA has/is been bargaining with each Prez candidate/party do you?

WSJ ARTICLE HERE


.

I don't want cannabis linked with OxyContin either. The category after that was something like cough syrup, what the hell. There's nothing in between OxyContin and cough syrup? It seems kinda crazy to me. There's three categories? Heroin, OxyContin and cough syrup?

Edit
Seems to me that it needs its own category.

CarolKing said:

I don't want cannabis linked with OxyContin either. The category after that was something like cough syrup, what the hell. There's nothing in between OxyContin and cough syrup? It seems kinda crazy to me. There's three categories? Heroin, OxyContin and cough syrup?

Edit
Seems to me that it needs its own category.

Click to expand...

Honestly too tired and too baked to bother, but if someone pulls up the drugs listed for Schedule 4 & 5, I think you'll probably find that it doesn't fit in there either. It should be DE-scheduled.

I sell all classes of pharmaceuticals into medical offices. I can assure you most reclassification is due to whoever paid the FDA the most to get easier access. There are some hard lined spots, but they reclassify drugs all the time willy nilly until you look into donations/job hopping from private toe public sector/companies funding FDA research.

If Marijuana had the lobby group that Hospira, Merck, and Sanofi do, this wouldn't even be an issue.

from https://www.dea.gov/druginfo/ds.shtml:

Drug Schedules

Drugs, substances, and certain chemicals used to make drugs are classified into five (5) distinct categories or schedules depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential. The abuse rate is a determinate factor in the scheduling of the drug; for example, Schedule I drugs are considered the most dangerous class of drugs with a high potential for abuse and potentially severe psychological and/or physical dependence. As the drug schedule changes-- Schedule II, Schedule III, etc., so does the abuse potential-- Schedule V drugs represents the least potential for abuse. A Listing of drugs and their schedule are located at Controlled Substance Act (CSA) Scheduling or CSA Scheduling by Alphabetical Order. These lists describes the basic or parent chemical and do not necessarily describe the salts, isomers and salts of isomers, esters, ethers and derivatives which may also be classified as controlled substances. These lists are intended as general references and are not comprehensive listings of all controlled substances.

Please note that a substance need not be listed as a controlled substance to be treated as a Schedule I substance for criminal prosecution. A controlled substance analogue is a substance which is intended for human consumption and is structurally or pharmacologically substantially similar to or is represented as being similar to a Schedule I or Schedule II substance and is not an approved medication in the United States. (See 21 U.S.C. §802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. §813 for the schedule.)

Schedule I

Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Some examples of Schedule I drugs are:

heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote

Schedule II

Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are:

Combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin

Schedule III

Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are:

Products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone

Schedule IV

Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are:

Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol

Schedule V

Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are:

cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin

yogoshio said:

I sell all classes of pharmaceuticals into medical offices. I can assure you most reclassification is due to whoever paid the FDA the most to get easier access. There are some hard lined spots, but they reclassify drugs all the time willy nilly until you look into donations/job hopping from private toe public sector/companies funding FDA research.

If Marijuana had the lobby group that Hospira, Merck, and Sanofi do, this wouldn't even be an issue.

Click to expand...

There were too many agendas in play, and no one wanted to cooperate or collaborate

yogoshio said:

I sell all classes of pharmaceuticals into medical offices. I can assure you most reclassification is due to whoever paid the FDA the most to get easier access. There are some hard lined spots, but they reclassify drugs all the time willy nilly until you look into donations/job hopping from private toe public sector/companies funding FDA research.

If Marijuana had the lobby group that Hospira, Merck, and Sanofi do, this wouldn't even be an issue.

Click to expand...

the the good thing and the problem with cannabis is its all people access potential. just thinking that weeds and pharmaceutical companies cannot get along together because weeds are just to wild....

The pharmaceutical companies want a cash cow that they can sell you lots of and that you can't make at home. If they had their druthers they would also prefer to fix prices at a high point and eliminate all competition. Not saying they are necessarily evil but big corporations go after profit so naturally some of their interests come into conflict with the interests of ordinary cannabis consumers. This is why it is so important and strategic to always insist upon legislation and initiatives that include legal home grows. If there is an alternative and competition to cannabis products provided by big corporations, this will help keep some of their greedy, less wholesome, and monopolistic instincts in check.

looney2nz said:

Schedule II

Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are:

Combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin

Schedule III

Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are:

Products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone

Click to expand...

This is either not current, or my pharmacy is making me jump through schedule 2 hoops for no reason.

grokit said:

This is either not current, or my pharmacy is making me jump through schedule 2 hoops for no reason.

Click to expand...

I grabbed it off of the dea.gov site just before I posted it. Which isn't to say that they are necessarily staying on top of their web publishing... I'll try to double check it.

These are all 'triplicate' form drugs (you have to pick up your prescription sheet in person, and it has extra DEA hurdles)